Americans for Safe Access

MAY 2, 2024

CANNABIS RESCHEDULING IS A VICTORY FOR PATIENTS BY PATIENTS Cannabis is being rescheduled because of its “currently accepted medical use in treatment in the United States.” After 50+ years of prohibition on access and research, it was the experience and research from state medical cannabis programs that made this qualification possible.

Patients 321

Patients Treatment Programs Access 321

Americans for Safe Access

JUNE 22, 2018

Thanks to the results from recently-permitted scientific studies and the untiring work of cannabis activist groups, more and more people are beginning to accept that cannabis is a successful form of treatment for certain medical conditions. Despite this, many patients out there are still hesitant to try it.

Treatment 189

Treatment Patients Conditions Cannabis 189

Project CBD

DECEMBER 15, 2021

Abandoned to their fate, desperately ill epileptic children can’t access life-saving cannabis treatments.

Treatment 341

Treatment Access Cannabis 341

Americans for Safe Access

APRIL 3, 2025

After exhausting all medications and available treatment options for Colton, his doctors mentioned medical cannabis treatment. Crista's passion for advocacy began when her youngest son, Colton, was diagnosed with intractable epilepsy just after he turned two.

Advocacy 155

Advocacy Epilepsy Treatment Education 155

NORML

MARCH 12, 2020

“It is imperative that we approve legislation such as the Veterans Equal Access Act so that the countless vets suffering from post-traumatic stress and other debilitating disorders have access to the safe and effective option of medical marijuana treatment.” Presently, V.A. We must reform our federal cannabis policy.”

Marijuana 363

Marijuana Chronic Pain Policy Access 363

Americans for Safe Access

APRIL 15, 2021

Across these states, millions of patients are demonstrating cannabis’ medicinal value through their treatments every day. However, the federal government continues to lag behind with drug classifications from an era where computers were the size of school busses.

Patients 312

Patients Access Medicine Treatment 312

NORML

MARCH 11, 2020

I introduced the Veterans Equal Access Act, HR 1647 because it is my responsibility as a Member of Congress to ensure that all Americans have access to medical treatment as recommended by their physicians. Today, you can make a difference and show your support for our nation’s veterans and the efficacy of medical cannabis.

Chronic Pain 336

Chronic Pain Marijuana Access Treatment 336

The Cannigma

AUGUST 5, 2022

Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.

Treatment 138

Treatment Research and Development Therapy Digestion 138

NORML

APRIL 30, 2020

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.” ” Among pain patients enrolled in medical cannabis access programs, most subjects report eventually decreasing or even eliminating their use of opiates.

Chronic Pain 347

Chronic Pain Clinical Trials Data Patients 347

NORML

JUNE 15, 2020

“This is common sense legislation that provides physicians, not lawmakers, the ability and discretion to decide what treatment options are best for their patients.". The post Louisiana: Governor Signs Bills Into Law Facilitating Expanded Cannabis Access for Patients appeared first on NORML.

Access 136

Access Patients Law Treatment 136

NORML

MARCH 30, 2020

They reported “circumstantial evidence” suggesting that CBD may possess antiviral acticity in a limited number of conditions, specifically in the treatment of hepatitis C and Karposi sarcoma. Misleading claims represent both a threat to public health and a violation of consumer access to accurate information.”

CBD 304

CBD Clinical Trials Data Treatment 304

United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments. Could marijuana be the answer?

Treatment 134

Treatment Cannabinoids Blood Pressure Patients 134

NORML

JULY 12, 2021

The lawsuit, which was filed by a 19-year-old patient who uses cannabis for the treatment of severe epilepsy, argues that the proposed changes will unduly restrict medical cannabis access among patients and will discourage physicians from participating in the program.

Epilepsy 243

Epilepsy Legalization Treatment Patients 243

Veriheal

SEPTEMBER 29, 2021

Gavin Newsom signed a bill known as Ryan’s Law requiring hospitals in the state to allow terminally ill patients access to medical cannabis for treatment and pain relief. hospitals currently prohibit the ingestion of cannabis on-site regardless of the treatment it can provide for patients—particularly those in hospice. .”

Access 119

Access Patients Law Treatment 119

Illinois News Joint

JANUARY 9, 2025

Providers are now able to begin certifying patients with those conditions for treatment with medical cannabis. IDPH looks forward to working with our medical providers to ensure appropriate access for individuals struggling with these newly approved conditions. Those four newly added conditions bring the total to 56.

Conditions 105

Conditions Treatment Chronic Pain Epilepsy 105

MMJ Recs

DECEMBER 10, 2023

While some states have embraced the therapeutic potential of cannabis and established robust medical marijuana programs, others lag behind, leaving patients without access to a potentially life-changing treatment. Disparities in access are primarily driven by the differing state regulations and policies surrounding medical marijuana.

Access 97

Access Marijuana Treatment Patients 97

Cannabis Law Report

AUGUST 20, 2021

The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. Many are finding that despite the treatment being approved, they are being denied access in their area.”. How much longer are we going to have to wait?

Access 105

Access Patients Media Treatment 105

NORML

JANUARY 6, 2023

“Cannabis has established efficacy in the treatment of multiple conditions, including chronic pain, and it possesses a safety profile that is either comparable or superior to other controlled substances.

Chronic Pain 225

Chronic Pain Patients Safety Treatment 225

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access.

Access 98

Access Patients Chronic Pain Conditions 98

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 212

Clinical Trials Chronic Pain Data Treatment 212

Veriheal

AUGUST 15, 2022

In their recently published study, titled “The Effects of Consuming Cannabis Flower for Treatment of Fatigue,” the UNM researchers proved that the Cannabis sativa plant instantly reduced feelings of fatigue in most consumers. The sessions were logged by a total of 1,224 people who had access to the app.

Treatment 102

Treatment Research and Development Sativa Cannabinoids 102

Cannabis Law Report

AUGUST 8, 2021

Advocacy group TheraPsil is teaming up with lawyers to pressure the government to grant access and develop regulations. And legal experts think patients are entitled to a reply, and are working alongside advocates to compel the government to give answers and provide access to treatment otherwise prohibited by drug laws.

Access 105

Access Patients Legalization Advocacy 105

NORML

AUGUST 12, 2019

Allows the existing state-legal marijuana industry to access financial services and enjoy the standard tax treatment available to all legal businesses. This also will pave the way for more scientific and medical research.

Legalization 279

Legalization Marijuana Decriminalization Policy 279

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “This year, my focus was on program improvements to further expand both access and therapeutic value to benefit the health and well-being of all Virginians.”

Law 263

Law Patients Access Oil 263

NORML

MAY 26, 2020

Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

Clinical Trials 283

Clinical Trials Chronic Pain Cannabinoids Patients 283

Americans for Safe Access

JULY 29, 2020

Just like prescription medication, diet and exercise, cannabis can impact other therapies and treatments you may be using, so it's important to make sure whoever you're working with has the full picture and can monitor your progress or make adjustments if needed. A big thank you to Debbie for her time and to ASA for all that they do.

Programs 246

Programs Therapy Medicine Patients 246

NORML

JUNE 10, 2020

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments. ” Furthermore, pain patients enrolled in medical cannabis access programs typically report decreasing or even eliminating their use of opiates after initiating cannabis therapy.

Chronic Pain 258

Chronic Pain Therapy Patients Topical 258

NORML

JUNE 11, 2019

Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs. Several peer-reviewed studies now document this trend. These conclusions are hardly unique. percent versus 44.8

Chronic Pain 205

Chronic Pain Programs Patients Access 205

Americans for Safe Access

AUGUST 12, 2024

territories, often serving as a crucial alternative when conventional treatments have failed or as a safer option compared to pharmaceuticals. Today, cannabis-based therapies provide relief to over 6 million Americans registered in medical cannabis programs in 38 states, D.C., and four of the five U.S.

Therapy 260

Therapy Pharmaceutical Treatment Programs 260

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Canna Care Docs

MARCH 27, 2025

This trend raises important questions about access, affordability, and the future of medical cannabis as a vital healthcare resource. The program aimed to provide safe, legal access to cannabis for patients with chronic conditions. This decrease has raised concerns about access to cannabis-based treatments for those who need them most.

Programs 52

Programs Recreational Dispensary Patients 52

NORML

MARCH 7, 2020

Legislation is pending, House Bill 268 and House Bill 528, to allow those convicted of simple marijuana possession to petition the court to restrict access to their records. Legislation is pending that would expand the pool of individuals eligible for medical cannabis access. GA resident? MN resident?

Legislation 253

Legislation Decriminalization Patients THC 253

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

NORML

MAY 21, 2019

.” Researchers concluded, “CBD’s potential to reduce cue-induced craving and anxiety provides a strong basis for further investigation of this phytocannabinoid as a treatment option for opioid use disorder.” In clinical models, CBD administration has been shown to reduce cravings for tobacco.

Clinical Trials 199

Clinical Trials CBD History Data 199

NORML

JANUARY 19, 2020

House Bill 1359 would create a 5 year medical marijuana pilot program, allowing patients to access their medicine from licensed dispensaries. Send a message to your lawmakers in support of medical marijuana access. Legislation is pending, Senate Bill 697, to expand access to medical marijuana. IN resident? NH resident?

Legislation 252

Legislation Decriminalization Access Patients 252

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? VA resident? West Virginia.

Legislation 253

Legislation Patients Decriminalization Access 253

MMJ Recs

JULY 9, 2024

Traditional treatments, while helpful to some extent, often come with limitations and side effects that can further burden individuals already dealing with a debilitating disease. Medical marijuana has emerged as a promising alternative treatment option for managing symptoms associated with MS.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111